Cochlear releases full-year numbers

Cochlear's revenue up on new products; profit impacted by operating expenses.

Cochlear
Source: Bloomberg

Key findings

- US and European sales improve
- Product releases in all divisions give FY15 a strong sales platform to excel
- Fundamentally: analysts upgrades expected – Technically: upside seen

For an exclusive break-down of the results, read Evan Lucas' Equity Matrix on Cochlear.

Cochlear

Revenue

Earnings per share

Expected

$806.50 million
$1.83

Actual

$820.9 million
$1.646

 

See our Australian earnings season break-down to keep up-to-date with key markets and potential near-term trading opportunities.

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.